Abstract
Pain is one of the most frequently reported symptoms by lung cancer patients. Opioids are frequently used to manage oncological pain. However, there is considerable interindividual variability in the response to opioids, which can result in ineffectiveness or adverse drug reactions (ADRs). This variability can have various causes, including genetic variability in the OPRM1 gene, which enc…